LCB
LIVE

Serial Number

98921341

Owner

LigaChem Biosciences Inc.

Attorney

Richard Y. Kim

Filing Date

Dec 24, 2024

Add to watchlist:

No watchlists yet
View on USPTO

LCB Trademark

Serial Number: 98921341 • Registration: 8091682

LCB is a trademark filed by LigaChem Biosciences Inc. on December 24, 2024. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

LigaChem Biosciences Inc. (4 trademarks)

10, Gukjegwahak 10-ro, Yuseong-gu

Entity Type: 03

Trademark Details

Filing Date

December 24, 2024

Registration Date

January 6, 2026

Published for Opposition

October 21, 2025

Goods & Services

Research and development of vaccines and medicines; biomedical research services; biological research and analysis; research of crude drugs; biochemical research and analysis; bacteriological research and analysis; drug discovery services; Research and development in the field of pharmaceuticals and biotechnology; development of pharmaceutical preparations and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; laboratory research in the field of pharmaceuticals; research on the subject of pharmaceuticals; drug development, namely, pharmaceutical drug development services in the fields of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; pharmaceutical research and development; pharmaceutical drug development services; consultancy pertaining to pharmacology; medical and pharmaceutical research services; research in the field of medical preparations; medical research laboratory services; medicine research, namely, medical research services relating to medicines in the fields of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; providing PAAS (platform as a service) featuring computer software used to conduct research and development in the field of pharmaceuticals, biotechnology and drugs; laboratory research services relating to pharmaceuticals; Technology research in the field of medical instruments; testing of pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others; chemical research and analysis

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 6, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 6, 2026 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Dec 18, 2025 DP1B
NOTICE OF ALLOWANCE CANCELLED
Dec 18, 2025 IUCN
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 16, 2025 NOAM
POST PUBLICATION AMENDMENT - ENTERED
Dec 5, 2025 CHPB
ASSIGNED TO PETITION STAFF
Dec 5, 2025 APET
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 21, 2025 NPUB
PUBLISHED FOR OPPOSITION
Oct 21, 2025 PUBO
TEAS POST PUBLICATION AMENDMENT RECEIVED
Oct 20, 2025 EPPA
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 15, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 18, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 16, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 16, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 16, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 9, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jul 9, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jul 9, 2025 CNRT
ASSIGNED TO EXAMINER
Jun 10, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 3, 2025 NWOS
NEW APPLICATION ENTERED
Dec 24, 2024 NWAP